Navigation Links
ArborGen and Senesco Announce Wood Quality Results
Date:7/7/2009

SUMMERVILLE, S.C., July 7 /PRNewswire/ -- ArborGen, LLC, a leader in forest tree improvement technologies, today announced wood quality results from ongoing field trials that are utilizing technology in-licensed from Senesco Technologies, Inc. (NYSE AMEX: SNT). The two companies had previously announced that trees that incorporate Senesco technology have shown significantly enhanced growth rates in 3-year-old field trials.

Selected trees from the field trials were harvested and their wood chemistry and density was assessed. There were no differences in key economic characteristics of wood, such as lignin, cellulose, and specific gravity, between the trees with the enhanced growth attributes and untreated control trees. This is good news as fast tree growth is often associated with lower wood quality.

"With several years of positive field trials, Senesco's technology has certainly given us confidence in the consistency of performance of this technology," said Barbara Wells, Ph.D., president and CEO of ArborGen. "Our collaboration with Senesco continues to produce very promising results that we expect will ultimately add to our portfolio of forestry products."

Bruce Galton, President and CEO of Senesco, said, "We believe ArborGen's results represent another step toward the commercial validation of our technology in the hands of our licensing partners. Partnering with companies with ArborGen's expertise allows for development of our technology for agricultural applications, while our internal research and development remains focused on our near term goal of filing an Investigational New Drug application with the FDA for our ongoing oncology work in multiple myeloma. We believe these results further reaffirm the broad applicability of Senesco's technology."

About ArborGen, LLC


'/>"/>

SOURCE ArborGen, LLC
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Senesco Technologies Closes on Additional $4.0 Million of Previously Announced Financing
2. Senesco Technologies Reports on Results of Preclinical Multiple Myeloma Studies
3. Senesco Technologies Reports Second Quarter Fiscal 2008 Financial Results
4. Senesco Technologies Regains Compliance With Amexs Continued Listing Requirements
5. Senesco Technologies Reports Third Quarter Fiscal 2008 Financial Results
6. Senesco Technologies to Present at BIO 2008 Business Forum
7. Senesco Signs a Supply Agreement for Polyplus-transfections Delivery System
8. Senesco Technologies Closes Remaining $3.0 Million of Previously Announced Financing
9. Senesco Technologies Announces Successful Completion of First Milestone Related to Agreement with Bayer CropScience
10. Senescos Preclinical Multiple Myeloma Data to be Presented at the 20th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
11. Senesco Appoints Harlan W. Waksal, M.D., to Board of Directors

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)..., STOCKHOLM, November 20 Karol...pean Investment Fund (EIF) has entered into a,co-i...tment fund will be,managed by Karolinska Developme...f early-stage pharmaceutical and medical technolog... in the co-investment fund. The agreement,represen...
(Date:11/19/2009)...le would like to be able to charge their cell phon...too often. A recent discovery made by UC San Diego...ercapacitors that could do just this. , In rece... , Prabhakar Bandaru, a professor in the UCSD Depa...ong with graduate student Mark Hoefer, have found ...
(Date:11/19/2009)... ,, BETHESDA, Md., Nov. 19 /PRNewswire-First... innovator in biotechnology for diabetes therapy, ...ing services to food, supplement, biotechnology an...sed the previously reported $6.3 million registere...,760,870 shares of its common stock and warrants t...
(Date:11/19/2009)... MUNSTER, Germany, November 19 ...led on November 16th, 2009 Flibanserin in the,indi...sia in Parkinson,s,disease for orphan drug status ...EA). Levodopa-induced dyskinesia is a complication... and a serious burden to some of those,affected, s...
Breaking Biology Technology:Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 2Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 3Nanotube defects equal better energy and storage systems 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2
...alifax-based consumer health products company reco...Nova Scotia, Jan. 27 Origin BioMed Inc., a privat..., today announced that it has been awarded as one ... , Red Herring Top 100 Global Companies are chosen...itions for North America, Europe and Asia Red Herr...
...EW YORK, Jan. 27 Technology and consulting firm, ...acle Partner Network, today announced year over ye...continue the positive trend in 2009. The company,...f flat to low single digit growth for the U.S. IT...rn affects IT services spending across most indust...
... ST. LOUIS and DURHAM, N.C., Jan. 27 As farmers.... Louis-based Monsanto,(NYSE: MON ) is exploring...e,traits through the seed. Monsanto,s new collabor...ed to do just that by expanding the benefits of,Mo...rmer customer. , Today, Monsanto announced tha...
Other Biology Technology:Origin BioMed Awarded Red Herring Top 100 Global Company 2Origin BioMed Awarded Red Herring Top 100 Global Company 3Fadel Partners Announces 13% Growth Despite IT Services Industry Downtrend 2New Collaboration Aims To Expand Seed-Based Technologies, Benefit Farmers 2New Collaboration Aims To Expand Seed-Based Technologies, Benefit Farmers 3New Collaboration Aims To Expand Seed-Based Technologies, Benefit Farmers 4
(Date:11/20/2009)...North Grafton, Mass., November 19, 2009 The estim...industry may be at risk of developing respiratory ...ccording to a questionnaire study undertaken earli...s Cummings School of Veterinary Medicine. , The ...arn workersfound that 50 percent of individuals wo...
(Date:11/20/2009)... This release is available in German . , In...cal Investigation , Dr. Stefanie Eyerich and Dr. K...Imperial College London and Istituto Dermopatico d...ng discovery. It represents a milestone on the way...ory skin diseases such as psoriasis and allergic r...
(Date:11/20/2009)...CHAMPAIGN, Ill. In a new study, researchers repor...ockers can have a helpful, or harmful, effect on t..., The study, which appears in the journal Circul...get both the alpha- and beta-receptors on the hear...s, while those that target only the beta-receptors...
Breaking Biology News(10 mins):Barn personnel experience higher-than-average rates of respiratory symptoms 2Discovery of new type of immune cells regulating inflammation in chronic diseases 2Carvedilol shown to have unique characteristics among beta blockers 2University of Toronto helps to barcode the worlds plants 9394 1University of Toronto helps to barcode the worlds plants 9394 2Microban Partners With YogaDirect com to Launch Yoga Mats With Zinc Antimicrobial Technology 13234 1Microban Partners With YogaDirect com to Launch Yoga Mats With Zinc Antimicrobial Technology 13234 2Valve Repair First in New England Done With Robotic Device 52959 1Valve Repair First in New England Done With Robotic Device 52959 2Valve Repair First in New England Done With Robotic Device 52959 3
...mproved aerodynamic shape for truck trailers by mo...ption and emissions of up to as much as 15%. Earli...dels and wind tunnel tests by TU Delft, have been ...r. This means that public-private platform PART (P...ced an application which can immediately be put in...
...e most common cause of episodic headache, and by f... visit. It affects some 15% of the population, inc...s a considerable burden on healthcare in both the ... last few years, great strides have been made in d...lity to common diseases, such as diabetes, Crohns ...
...y: New evidence has emerged that, contrary to some... associated with an increased risk of heart proble...cancer recurring. , In a study presented today (T...nce (EBCC-6) in Berlin, the researcher, Dr Alain M...g news for women. , AIs, such as letrozole, anast...
Other Biology News:Aerodynamic trailer cuts fuel and emissions by up to 15 percent 2Concentrating on different aspects of pain leads to breakthrough in migraine genetics 2New research shows no link between aromatase inhibitors and cardiovascular problems 2New research shows no link between aromatase inhibitors and cardiovascular problems 3
Goat Anti-SDF-1 beta / PBSF Polyclonal Antibody, Unconjugated from Sigma-Aldrich
Immulon 4 HBX 1x12 Strip from Thermo Scientific
BspT107 I (HgiC I, Ban I) from Takara Mirus Bio
Enterokinase from bovine intestine from Sigma-Aldrich
Biology Products: